Skip to main content
. 2022 Sep;11(9):1577–1587. doi: 10.21037/tp-22-297

Figure 3.

Figure 3

Clinical course of treatment for movement disorders. Antidyskinetic dose-response curves for Tiapride hydrochloride and Oxcarbazepine as the duration of the movement disorders during hospitalization before and after oral administration and increasing doses. MDs, movement disorders; MRI, magnetic resonance imaging; EEG, electroencephalogram.